Where can I find the detailed financial results for IDEXX Laboratories' second quarter of 2025?

The detailed financial results for the second quarter ended June 30, 2025, are provided in the press release furnished as Exhibit 99.1 to this Current Report on Form 8-K, filed on August 4, 2025.

Is this filing providing new audited financial statements?

No, this filing primarily announces the results of operations and financial condition through a furnished press release (Exhibit 99.1). It does not appear to include new audited financial statements as part of the core filing.

What is the effective date of the financial information being reported?

The financial information being announced pertains to the second quarter ended June 30, 2025.

What is the significance of the statement that the information is 'furnished' and not 'filed'?

When information is furnished under Item 2.02, it means it's being provided to the SEC for public dissemination but is generally not subject to the same liability provisions under Section 18 of the Securities Exchange Act of 1934 as information that is formally 'filed'.

IDXX 8-K: Earnings & Results

Summary

IDEXX Laboratories, Inc. (IDXX) has filed a Current Report on Form 8-K to announce its financial results for the second quarter ended June 30, 2025. The report primarily furnishes a press release detailing these results, which investors should review for comprehensive financial performance insights. This filing does not contain new audited financial statements but serves as the official channel for disseminating the company's quarterly earnings information as of August 4, 2025.

Key Highlights

1IDEXX Laboratories announced its financial results for the second quarter ended June 30, 2025, via an 8-K filing.
2The press release containing the second quarter results is furnished as Exhibit 99.1 to the filing.
3The filing was made on August 4, 2025.
4The information furnished is for the quarter ending June 30, 2025.
5The report clarifies that the information furnished under Item 2.02 and Exhibit 99.1 is not deemed 'filed' for Section 18 of the Exchange Act.
6The Chief Financial Officer, Andrew Emerson, signed the filing on behalf of the company.

IDEXX LABORATORIES INC /DE 8-K Report, Financial Results (Aug 4, 2025)

Summary

Key Highlights

Frequently Asked Questions